Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Computing & Software • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering
5 pending office actions • 4 clients • 5 examiners • 5 art units • 0 of 5 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Patnstr, APC has managed 341 career applications in the Biotechnology & Pharmaceuticals technology area. The firm has achieved a resolved allowance rate pct of 62.15 for these applications. Currently, the firm is overseeing 6 pending office actions.
The prosecution of these 341 career applications involves an avg office actions per allowance of 3.29. This figure indicates that the firm's 62.15 resolved allowance rate pct is reached through multiple rounds of negotiation with the USPTO. The firm's current management of 6 pending office actions shows an ongoing effort to secure patent rights in the biotechnology sector.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (60%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SANDERSON, LEE E | 1 | 45.4% | +44.6% |
| GO, JOHN PHILIP | 1 | 34.1% | +43.1% |
| WU, TONY | 1 | 53.4% | +26.5% |
| NG, HENRY | 1 | 64.1% | +52.2% |
| HELM, CARALYNNE E | 1 | 28.9% | +49.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17962543 | ENHANCED DERMAL PATCH FOR TREATING MENSTRUAL PAIN | HELM, CARALYNNE E | 26d |
| 18296443 | AUTONOMOUS DOSE DETERMINATION FOR PEN DELIVERY OF MEDICAMENT | NG, HENRY | 29d |
| 18354009 | AMBULATORY MEDICAMENT PUMP WITH DISTRESS NOTIFICATIONS | GO, JOHN PHILIP | 34d |
| 18332094 | LATENCY FREE REMOTE PROCEDURE SUPPORT PLATFORM, PROCESSES AND PRODUCTS THEREBY | WU, TONY | 65d |
| 19362533 | SELECTIVE EXTRACTION OF CANNABINOIDS, PIGMENTS, AND LIPIDS FROM PLANT MATTER | SANDERSON, LEE E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17962543 | ENHANCED DERMAL PATCH FOR TREATING MENSTRUAL PAIN | HELM, CARALYNNE E | 26d |
| 18296443 | AUTONOMOUS DOSE DETERMINATION FOR PEN DELIVERY OF MEDICAMENT | NG, HENRY | 29d |
| 18354009 | AMBULATORY MEDICAMENT PUMP WITH DISTRESS NOTIFICATIONS | GO, JOHN PHILIP | 34d |
| 18332094 | LATENCY FREE REMOTE PROCEDURE SUPPORT PLATFORM, PROCESSES AND PRODUCTS THEREBY | WU, TONY | 65d |
| 19362533 | SELECTIVE EXTRACTION OF CANNABINOIDS, PIGMENTS, AND LIPIDS FROM PLANT MATTER | SANDERSON, LEE E | — |
| Client (Assignee) | Pending OAs |
|---|---|
| BETA BIONICS, INC. | 2 |
| Global Ip Holdings LLC | 1 |
| Harrison Bay Life Sciences, LLC | 1 |
| Nfi Corp. | 1 |
| Art Unit | Apps |
|---|---|
| 3991 | 1 |
| 3681 | 1 |
| 2166 | 1 |
| 3741 | 1 |
| 1615 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19362533 | SELECTIVE EXTRACTION OF CANNABINOIDS, PIGMENTS, AND LIPIDS FROM PLANT MATTER | Global Ip Holdings LLC | SANDERSON, LEE E | 3991 | §102§103§112Other | Non-Final OA | — | Pending | Oct 20, 2025 |
| 18354009 | AMBULATORY MEDICAMENT PUMP WITH DISTRESS NOTIFICATIONS | BETA BIONICS, INC. | GO, JOHN PHILIP | 3681 | §101§102§103§112Other | Non-Final OA | 34d | Pending | Jul 18, 2023 |
| 18332094 | LATENCY FREE REMOTE PROCEDURE SUPPORT PLATFORM, PROCESSES AND PRODUCTS THEREBY | Harrison Bay Life Sciences, LLC | WU, TONY | 2166 | §103§112 | Non-Final OA | 65d | Pending | Jun 09, 2023 |
| 18296443 | AUTONOMOUS DOSE DETERMINATION FOR PEN DELIVERY OF MEDICAMENT | BETA BIONICS, INC. | NG, HENRY | 3741 | §101§102§103 | Non-Final OA | 29d | Pending | Apr 06, 2023 |
| 17962543 | ENHANCED DERMAL PATCH FOR TREATING MENSTRUAL PAIN | Nfi Corp. | HELM, CARALYNNE E | 1615 | §101§102§103§112 | Non-Final OA | 26d | Pending | Oct 09, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial